1022158-37-7 Usage
Uses
Used in Pharmaceutical Research:
3H-Imidazo[4,5-b]pyridine-6-methanol is utilized as a chemical building block for the synthesis of new drugs, particularly in the development of pharmaceuticals targeting oncological and neurological disorders. Its unique structure allows for the creation of novel compounds with potential therapeutic effects.
Used in Oncology:
In the field of oncology, 3H-Imidazo[4,5-b]pyridine-6-methanol is employed as a precursor in the development of anticancer agents. Its potential biological activity makes it a valuable component in the creation of drugs aimed at treating various types of cancer.
Used in Neuroscience:
3H-Imidazo[4,5-b]pyridine-6-methanol is also used in the field of neuroscience for the synthesis of compounds that may have neuroprotective or other beneficial effects on the nervous system, contributing to the treatment of neurological disorders.
Used in Antimicrobial Applications:
Research has indicated that 3H-Imidazo[4,5-b]pyridine-6-methanol may possess antimicrobial properties, making it a potential candidate for the development of new antimicrobial agents to combat resistant bacterial strains.
Used in Anti-inflammatory Applications:
3H-Imidazo[4,5-b]pyridine-6-methanol's potential anti-inflammatory properties suggest its use in the development of anti-inflammatory drugs, which could be beneficial in treating a range of inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1022158-37-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,1,5 and 8 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1022158-37:
(9*1)+(8*0)+(7*2)+(6*2)+(5*1)+(4*5)+(3*8)+(2*3)+(1*7)=97
97 % 10 = 7
So 1022158-37-7 is a valid CAS Registry Number.
1022158-37-7Relevant academic research and scientific papers
HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS
-
Page/Page column 161, (2008/12/05)
Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.
